Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Assessing treatment responses in hepatocellular carcinoma (HCC) is challenging, and alternative radiologic methods of measuring treatment response are required. Modified Response Evaluation Criteria in Solid Tumors (mRECIST) for HCC and alpha-fetoprotein (AFP) levels were assess...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Cancer
Autors principals: Raoul, Jean-Luc, Park, Joong-Won, Kang, Yoon-Koo, Finn, Richard S, Kim, Jun Suk, Yeo, Winnie, Polite, Blasé N, Chao, Yee, Walters, Ian, Baudelet, Christine, Lencioni, Riccardo
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531422/
https://ncbi.nlm.nih.gov/pubmed/26280005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343872
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars